US5776429A
(en)
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5874062A
(en)
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
GB9216082D0
(en)
*
|
1992-07-28 |
1992-09-09 |
Univ Nottingham |
Lymphatic delivery composition
|
US5871710A
(en)
*
|
1992-09-04 |
1999-02-16 |
The General Hospital Corporation |
Graft co-polymer adducts of platinum (II) compounds
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
GB9406094D0
(en)
*
|
1994-03-28 |
1994-05-18 |
Univ Nottingham And University |
Polymer microspheres and a method of production thereof
|
US6007845A
(en)
*
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US6040295A
(en)
|
1995-01-13 |
2000-03-21 |
Genemedicine, Inc. |
Formulated nucleic acid compositions and methods of administering the same for gene therapy
|
US5612052A
(en)
*
|
1995-04-13 |
1997-03-18 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
US6413539B1
(en)
|
1996-10-31 |
2002-07-02 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
KR0180334B1
(ko)
*
|
1995-09-21 |
1999-03-20 |
김윤 |
블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
|
US5834025A
(en)
*
|
1995-09-29 |
1998-11-10 |
Nanosystems L.L.C. |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
|
WO1997017063A1
(en)
|
1995-11-09 |
1997-05-15 |
Microbiological Research Authority |
Microencapsulated dna for vaccination and gene therapy
|
US5985312A
(en)
*
|
1996-01-26 |
1999-11-16 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US6368586B1
(en)
|
1996-01-26 |
2002-04-09 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US5611344A
(en)
*
|
1996-03-05 |
1997-03-18 |
Acusphere, Inc. |
Microencapsulated fluorinated gases for use as imaging agents
|
AU721209B2
(en)
*
|
1996-03-05 |
2000-06-29 |
Acusphere, Inc. |
Microencapsulated fluorinated gases for use as imaging agents
|
DE69736981D1
(de)
|
1996-05-01 |
2007-01-04 |
Imarx Pharmaceutical Corp |
In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
|
US5837221A
(en)
*
|
1996-07-29 |
1998-11-17 |
Acusphere, Inc. |
Polymer-lipid microencapsulated gases for use as imaging agents
|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
WO1998010798A1
(en)
|
1996-09-11 |
1998-03-19 |
Imarx Pharmaceutical Corp. |
Improved methods for diagnostic imaging using a contrast agent and a vasodilator
|
US6331289B1
(en)
|
1996-10-28 |
2001-12-18 |
Nycomed Imaging As |
Targeted diagnostic/therapeutic agents having more than one different vectors
|
WO1998018498A2
(en)
*
|
1996-10-28 |
1998-05-07 |
Marsden, John, Christopher |
Improvements in or relating to diagnostic/therapeutic agents
|
CA2270120A1
(en)
|
1996-10-28 |
1998-05-07 |
Pal Rongved |
Improvements in or relating to diagnostic/therapeutic agents
|
US6261537B1
(en)
|
1996-10-28 |
2001-07-17 |
Nycomed Imaging As |
Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
|
US6090800A
(en)
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US6537246B1
(en)
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
ATE377414T1
(de)
*
|
1997-04-30 |
2007-11-15 |
Point Biomedical Corp |
Mikropartikel, geeignet als kontrastmittel im ultraschall und zur wirkstoffgabe in den blutkreislauf
|
US20020159951A1
(en)
*
|
1997-05-06 |
2002-10-31 |
Unger Evan C. |
Novel targeted compositions for diagnostic and therapeutic use
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US20020039594A1
(en)
*
|
1997-05-13 |
2002-04-04 |
Evan C. Unger |
Solid porous matrices and methods of making and using the same
|
US6275726B1
(en)
*
|
1997-05-15 |
2001-08-14 |
Board Of Regents, The University Of Texas System |
Methods of enhanced light transmission through turbid biological media
|
US6045777A
(en)
*
|
1997-06-30 |
2000-04-04 |
Acusphere, Inc. |
Method for enhancing the echogenicity and decreasing the attenuation of microencapsulated gases
|
US6165440A
(en)
*
|
1997-07-09 |
2000-12-26 |
Board Of Regents, The University Of Texas System |
Radiation and nanoparticles for enhancement of drug delivery in solid tumors
|
US6211249B1
(en)
*
|
1997-07-11 |
2001-04-03 |
Life Medical Sciences, Inc. |
Polyester polyether block copolymers
|
US6287558B1
(en)
|
1997-08-01 |
2001-09-11 |
Biohybrio Technologies Llc |
Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
|
US6548047B1
(en)
*
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
US6254890B1
(en)
*
|
1997-12-12 |
2001-07-03 |
Massachusetts Institute Of Technology |
Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids
|
KR20010015856A
(ko)
*
|
1997-12-12 |
2001-02-26 |
마크로메드 인코퍼레이션 |
단백질 변성용으로 헤테로 작용기를 가진 별 모양의폴리(에틸렌글리콜)
|
US6123923A
(en)
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
DE19813174A1
(de)
*
|
1998-03-25 |
1999-05-27 |
Schering Ag |
Mikropartikel aus Polymeren und mindestens einer gerüstbildenden Komponente und ihre Herstellung und Verwendung in der Ultraschalldiagnostik und zur ultraschallinduzierten Wirkstofffreisetzung
|
US20030059465A1
(en)
*
|
1998-05-11 |
2003-03-27 |
Unger Evan C. |
Stabilized nanoparticle formulations of camptotheca derivatives
|
KR19990085365A
(ko)
*
|
1998-05-16 |
1999-12-06 |
허영섭 |
지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
|
EP1079812A4
(de)
*
|
1998-05-20 |
2001-12-12 |
Liposome Co Inc |
Neue teilchenförmige zubereitungen
|
ES2216517T3
(es)
|
1998-05-29 |
2004-10-16 |
Skyepharma Canada Inc. |
Composiciones de microcapsulas termoprotegidas y procedimiento para su esterilizacion terminal con vapor.
|
GB9814507D0
(en)
*
|
1998-07-03 |
1998-09-02 |
Univ Southampton |
A method and apparatus for controlling pests
|
US7343710B2
(en)
*
|
1998-07-03 |
2008-03-18 |
I.D.A Limited |
Method and apparatus for controlling pests
|
US6179862B1
(en)
|
1998-08-14 |
2001-01-30 |
Incept Llc |
Methods and apparatus for in situ formation of hydrogels
|
US6632457B1
(en)
*
|
1998-08-14 |
2003-10-14 |
Incept Llc |
Composite hydrogel drug delivery systems
|
JP4159254B2
(ja)
*
|
1998-08-14 |
2008-10-01 |
インセプト エルエルシー |
ヒドロゲルのインサイチュ形成のための方法および装置
|
US6143314A
(en)
*
|
1998-10-28 |
2000-11-07 |
Atrix Laboratories, Inc. |
Controlled release liquid delivery compositions with low initial drug burst
|
WO2000029206A1
(en)
*
|
1998-11-13 |
2000-05-25 |
Sensor Technologies Inc. |
Monodisperse preparations useful with implanted devices
|
CA2349203C
(en)
|
1998-11-20 |
2013-05-21 |
Rtp Pharma Inc. |
Dispersible phospholipid stabilized microparticles
|
US6365173B1
(en)
|
1999-01-14 |
2002-04-02 |
Efrat Biopolymers Ltd. |
Stereocomplex polymeric carriers for drug delivery
|
US6045826A
(en)
*
|
1999-04-02 |
2000-04-04 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
DE19921088C2
(de)
*
|
1999-04-30 |
2003-08-07 |
Magforce Applic Gmbh |
Stent zur Offenhaltung gangartiger Strukturen
|
US7829064B2
(en)
|
1999-05-10 |
2010-11-09 |
Immunomedics, Inc. |
Anti-CD74 immunoconjugates and methods
|
US8119101B2
(en)
|
1999-05-10 |
2012-02-21 |
The Ohio State University |
Anti-CD74 immunoconjugates and methods of use
|
US8383081B2
(en)
|
1999-05-10 |
2013-02-26 |
Immunomedics, Inc. |
Anti-CD74 immunoconjugates and methods of use
|
US6426145B1
(en)
|
1999-05-20 |
2002-07-30 |
Scimed Life Systems, Inc. |
Radiopaque compositions for visualization of medical devices
|
AU5218500A
(en)
*
|
1999-06-22 |
2001-01-09 |
Aventis Research & Technologies Gmbh & Co. Kg |
Stable, radioactively marked nanoparticles, method for the production and utilization thereof
|
DE19930729A1
(de)
*
|
1999-07-05 |
2001-01-11 |
Achim Goepferich |
Blockcopolymere zur Herstellung biomimetischer Oberflächen
|
EP1202671A4
(de)
|
1999-08-13 |
2004-11-10 |
Point Biomedical Corp |
Mikropartikel verwendbar als ultraschallkontrastmittel für das lymphsystem
|
EP1202670A4
(de)
*
|
1999-08-13 |
2004-11-10 |
Point Biomedical Corp |
Hohle mikrokugeln mit kontrollierter zerbrechlichkeit zur medizinischen verwendung
|
US20020041898A1
(en)
*
|
2000-01-05 |
2002-04-11 |
Unger Evan C. |
Novel targeted delivery systems for bioactive agents
|
AU2001247417A1
(en)
*
|
2000-03-14 |
2001-09-24 |
Trustees Of Tufts College |
Cross-reactive sensors
|
FR2809112B1
(fr)
*
|
2000-05-16 |
2004-05-07 |
Centre Nat Rech Scient |
Materiaux a base de polymeres biodegradables et son procede de preparation
|
WO2002036073A2
(en)
*
|
2000-11-02 |
2002-05-10 |
Smithkline Beecham Corporation |
Receptor antagonist-lipid conjugates and delivery vehicles containing same
|
US7378280B2
(en)
|
2000-11-16 |
2008-05-27 |
California Institute Of Technology |
Apparatus and methods for conducting assays and high throughput screening
|
US6495154B1
(en)
*
|
2000-11-21 |
2002-12-17 |
Vivus Inc. |
On demand administration of clomipramine and salts thereof to treat premature ejaculation
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US6869617B2
(en)
*
|
2000-12-22 |
2005-03-22 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US20020142304A1
(en)
*
|
2001-03-09 |
2002-10-03 |
Anderson Daniel G. |
Uses and methods of making microarrays of polymeric biomaterials
|
US8137699B2
(en)
*
|
2002-03-29 |
2012-03-20 |
Trustees Of Princeton University |
Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use
|
KR100463167B1
(ko)
*
|
2001-04-13 |
2004-12-23 |
주식회사 태평양 |
고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물
|
US20040126900A1
(en)
*
|
2001-04-13 |
2004-07-01 |
Barry Stephen E |
High affinity peptide- containing nanoparticles
|
US7153703B2
(en)
*
|
2001-05-14 |
2006-12-26 |
Board Of Trustees Of The University Of Arkansas N. A. |
Synthesis of stable colloidal nanocrystals using organic dendrons
|
IL158862A0
(en)
*
|
2001-05-21 |
2004-05-12 |
Nektar Therapeutics |
An insulin composition for pulmonary administration
|
AU2002320058A1
(en)
*
|
2001-06-06 |
2002-12-16 |
The General Hspital Corporation |
Magnetic-nanoparticle conjugates and methods of use
|
WO2002100172A1
(en)
*
|
2001-06-11 |
2002-12-19 |
Xenoport, Inc. |
Administration of agents via the pept-2 transporter
|
EP1406593B1
(de)
*
|
2001-06-22 |
2010-08-25 |
Johns Hopkins University School of Medicine |
Biologisch abbaubare polymerzusammensetzungen, zusammensetzungen und damit in beziehung stehende verwendungen
|
WO2003017987A1
(en)
*
|
2001-08-31 |
2003-03-06 |
Mcgill University |
Biodegradable polymeric nanocapsules and uses thereof
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
MXPA04002446A
(es)
|
2001-09-26 |
2004-07-23 |
Baxter Int |
Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
|
NZ532198A
(en)
*
|
2001-10-18 |
2006-03-31 |
Samyang Corp |
Polymeric micelle composition of an amphiphilic block copolymer and a polylactic acid derivative
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
AU2002351626A1
(en)
*
|
2001-12-21 |
2003-07-15 |
Celator Technologies Inc. |
Improved polymer-lipid delivery vehicles
|
US9770517B2
(en)
|
2002-03-01 |
2017-09-26 |
Immunomedics, Inc. |
Anti-Trop-2 antibody-drug conjugates and uses thereof
|
US20040076586A1
(en)
*
|
2002-03-28 |
2004-04-22 |
Reinhard Koening |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
US6919068B2
(en)
*
|
2002-05-17 |
2005-07-19 |
Point Biomedical Corporation |
Method of preparing gas-filled polymer matrix microparticles useful for echographic imaging
|
US7670623B2
(en)
|
2002-05-31 |
2010-03-02 |
Materials Modification, Inc. |
Hemostatic composition
|
JP4723244B2
(ja)
*
|
2002-07-19 |
2011-07-13 |
オメロス コーポレイション |
生分解性トリブロックコポリマー、その合成方法、ならびにそれから作製されるヒドロゲルおよび生体材料
|
FR2842737B1
(fr)
*
|
2002-07-25 |
2006-01-27 |
Centre Nat Rech Scient |
Particules revetues en surface de hyaluronane ou d'un de ses derives et leur utilisation a titre de vecteurs biologiques pour des matieres actives
|
US20040028804A1
(en)
*
|
2002-08-07 |
2004-02-12 |
Anderson Daniel G. |
Production of polymeric microarrays
|
US7563507B2
(en)
*
|
2002-08-16 |
2009-07-21 |
University Of Massachusetts |
Pyridine and related ligand compounds, functionalized nanoparticulate composites and methods of preparation
|
US7273904B2
(en)
|
2002-10-03 |
2007-09-25 |
The Board Of Trustees Of The University Of Arkansas |
Nanocrystals in ligand boxes exhibiting enhanced chemical, photochemical, and thermal stability, and methods of making the same
|
US20040161424A1
(en)
*
|
2002-10-08 |
2004-08-19 |
Xenoport |
Human organic solute transporters
|
US20040086432A1
(en)
*
|
2002-10-31 |
2004-05-06 |
Labarge William J. |
Reformer, systems utilizing the reformer, and methods for operating the systems
|
US7094730B2
(en)
*
|
2002-10-31 |
2006-08-22 |
Delphi Technologies, Inc. |
Gas treatment device, methods for making and using the same, and a vehicle exhaust system
|
KR20050088079A
(ko)
|
2002-11-15 |
2005-09-01 |
이데닉스 (케이만) 리미티드 |
2'-분지형 뉴클레오시드 및 플라비비리다에 돌연변이
|
US7560160B2
(en)
|
2002-11-25 |
2009-07-14 |
Materials Modification, Inc. |
Multifunctional particulate material, fluid, and composition
|
US8420086B2
(en)
|
2002-12-13 |
2013-04-16 |
Immunomedics, Inc. |
Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases
|
US7007972B1
(en)
|
2003-03-10 |
2006-03-07 |
Materials Modification, Inc. |
Method and airbag inflation apparatus employing magnetic fluid
|
US20040185108A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Short Robert E. |
Method of preparing gas-filled polymer matrix microparticles useful for delivering drug
|
US8518304B1
(en)
|
2003-03-31 |
2013-08-27 |
The Research Foundation Of State University Of New York |
Nano-structure enhancements for anisotropic conductive material and thermal interposers
|
US7645512B1
(en)
*
|
2003-03-31 |
2010-01-12 |
The Research Foundation Of The State University Of New York |
Nano-structure enhancements for anisotropic conductive adhesive and thermal interposers
|
WO2004089345A1
(en)
*
|
2003-04-03 |
2004-10-21 |
Semafore Pharmaceuticals Inc. |
Bone targeting of biodegradable drug-containing nanoparticles
|
EP1620002B1
(de)
*
|
2003-04-24 |
2012-01-04 |
The Board Of Regents, The University Of Texas System |
Nichtinvasive blutanalyse durch optische sondierung der venen unter der zunge
|
US20040224030A1
(en)
*
|
2003-05-06 |
2004-11-11 |
Shastri Venkatram R. |
Microsphere delivery systems
|
US6982501B1
(en)
|
2003-05-19 |
2006-01-03 |
Materials Modification, Inc. |
Magnetic fluid power generator device and method for generating power
|
US8651113B2
(en)
*
|
2003-06-18 |
2014-02-18 |
Swr&D Inc. |
Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
|
US7344491B1
(en)
|
2003-11-26 |
2008-03-18 |
Nanobiomagnetics, Inc. |
Method and apparatus for improving hearing
|
US7723311B2
(en)
*
|
2003-06-18 |
2010-05-25 |
Nanobiomagnetics, Inc. |
Delivery of bioactive substances to target cells
|
US20040258614A1
(en)
*
|
2003-06-20 |
2004-12-23 |
University Of Maryland, Baltimore |
Microparticles for microarterial imaging and radiotherapy
|
ES2226567B1
(es)
*
|
2003-06-20 |
2006-07-01 |
Universidad De Santiago De Compostela |
Nanoparticulas de acido hialuronico.
|
WO2005002643A2
(en)
*
|
2003-06-24 |
2005-01-13 |
Johns Hopkins University |
Method and products for delivering biological molecules to cells using multicomponent nanostructures
|
ES2232287B1
(es)
*
|
2003-07-04 |
2006-11-01 |
Advanced In Vitro Cell Technologies, S.L. |
Nanoparticulas de derivados polioxietilenados.
|
US7200956B1
(en)
|
2003-07-23 |
2007-04-10 |
Materials Modification, Inc. |
Magnetic fluid cushioning device for a footwear or shoe
|
US7790141B2
(en)
*
|
2003-08-11 |
2010-09-07 |
Pathak Holdings, Llc |
Radio-opaque compounds, compositions containing same and methods of their synthesis and use
|
US20050042298A1
(en)
*
|
2003-08-20 |
2005-02-24 |
Pardridge William M. |
Immunonanoparticles
|
US20050136536A1
(en)
*
|
2003-09-15 |
2005-06-23 |
Anderson Daniel G. |
Embryonic epithelial cells
|
US7448389B1
(en)
|
2003-10-10 |
2008-11-11 |
Materials Modification, Inc. |
Method and kit for inducing hypoxia in tumors through the use of a magnetic fluid
|
US20050084513A1
(en)
*
|
2003-10-21 |
2005-04-21 |
Board Of Regents |
Nanocoating for improving biocompatibility of medical implants
|
AU2004285595A1
(en)
|
2003-10-31 |
2005-05-12 |
Point Biomedical Corporation |
Reconstitutable microsphere compositions useful as ultrasonic contrast agents
|
US7608240B2
(en)
*
|
2003-12-05 |
2009-10-27 |
Board Of Trustees Of The University Of Arkansas |
Nanotubes for cancer therapy and diagnostics
|
US20080305048A1
(en)
*
|
2003-12-10 |
2008-12-11 |
The General Hospital Corporation |
Self-Assembling Nanoparticle Conjugates
|
WO2005072710A2
(en)
*
|
2004-01-28 |
2005-08-11 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
EP1711163A2
(de)
*
|
2004-02-05 |
2006-10-18 |
Baxter International Inc. |
Unter verwendung von selbststabilisierenden mitteln hergestellte dispersionen
|
US9550838B2
(en)
|
2004-02-13 |
2017-01-24 |
Ibc Pharmaceuticals, Inc. |
Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
|
US8883160B2
(en)
*
|
2004-02-13 |
2014-11-11 |
Ibc Pharmaceuticals, Inc. |
Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
|
US7632784B2
(en)
*
|
2004-04-17 |
2009-12-15 |
Rokhvarger Anatoly E |
Sintered ceramic composite lead with superconductive nano-architecture
|
ES2246694B1
(es)
*
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Nanoparticulas pegiladas.
|
ES2246695B1
(es)
*
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
|
US8012457B2
(en)
|
2004-06-04 |
2011-09-06 |
Acusphere, Inc. |
Ultrasound contrast agent dosage formulation
|
WO2006004774A2
(en)
*
|
2004-06-28 |
2006-01-12 |
Stanford University |
Laulimalide analogues as therapeutic agents
|
WO2006080951A2
(en)
*
|
2004-07-01 |
2006-08-03 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
US7297786B2
(en)
|
2004-07-09 |
2007-11-20 |
University Of Iowa Research Foundation |
RNA interference in respiratory epitheial cells
|
WO2006014626A2
(en)
*
|
2004-07-19 |
2006-02-09 |
Celator Pharmaceuticals, Inc. |
Partuculate constructs for release of active agents
|
US8357391B2
(en)
|
2004-07-30 |
2013-01-22 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages
|
WO2006039369A1
(en)
*
|
2004-09-29 |
2006-04-13 |
Alza Corporation |
Microparticles and nanoparticles containing a lipopolymer
|
US9492400B2
(en)
*
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
US20060198891A1
(en)
*
|
2004-11-29 |
2006-09-07 |
Francois Ravenelle |
Solid formulations of liquid biologically active agents
|
US8394410B2
(en)
*
|
2005-01-20 |
2013-03-12 |
Massachusetts Institute Of Technology |
Soft polylactides
|
US7611494B2
(en)
*
|
2005-02-08 |
2009-11-03 |
Confluent Surgical, Inc. |
Spray for fluent materials
|
AU2006218454B2
(en)
|
2005-03-03 |
2011-11-17 |
Immunomedics, Inc. |
Humanized L243 antibodies
|
US9707302B2
(en)
|
2013-07-23 |
2017-07-18 |
Immunomedics, Inc. |
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer
|
US10058621B2
(en)
|
2015-06-25 |
2018-08-28 |
Immunomedics, Inc. |
Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic cancers
|
WO2006106513A2
(en)
*
|
2005-04-05 |
2006-10-12 |
Bar-Ilan University |
New core and core-shell nanoparticles containing iodine for x-ray imaging
|
US8349332B2
(en)
|
2005-04-06 |
2013-01-08 |
Ibc Pharmaceuticals, Inc. |
Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
|
US8475794B2
(en)
|
2005-04-06 |
2013-07-02 |
Ibc Pharmaceuticals, Inc. |
Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases
|
KR100806669B1
(ko)
|
2005-06-23 |
2008-02-26 |
김정환 |
나노 입자-생체 복합체
|
JP2009502261A
(ja)
*
|
2005-07-25 |
2009-01-29 |
ナノテクノロジー ビクトリア ピーティーワイ リミテッド |
マイクロアレイデバイス
|
US20080184618A1
(en)
*
|
2005-08-03 |
2008-08-07 |
Amcol International |
Virus-Interacting Layered Phyllosilicates and Methods of Use
|
US20100272769A1
(en)
*
|
2005-08-03 |
2010-10-28 |
Amcol International |
Virus-, Bacteria-, and Fungi-Interacting Layered Phyllosilicates and Methods of Use
|
US20070031512A1
(en)
*
|
2005-08-03 |
2007-02-08 |
Amcol International Corporation |
Virus-interacting layered phyllosilicates and methods of inactivating viruses
|
JP5295769B2
(ja)
|
2005-08-31 |
2013-09-18 |
ティツー・バイオシステムズ・インコーポレーテッド |
分析物を検出するためのnmr装置
|
KR100718329B1
(ko)
*
|
2005-09-08 |
2007-05-14 |
광주과학기술원 |
다당류로 기능화된 수화젤막을 가지는 나노입자와 이를포함하는 서방형 약물전달시스템 및 그 제조방법
|
US20070248675A1
(en)
*
|
2005-09-08 |
2007-10-25 |
Gwangju Institute Of Science And Technology |
Composite comprising polysaccharide-functionalized nanoparticle and hydrogel matrix, a drug delivery system and a bone defect replacement matrix for sustained release comprising the same, and the preparation method thereof
|
US20070264199A1
(en)
*
|
2005-09-26 |
2007-11-15 |
Labhasetwar Vinod D |
Magnetic nanoparticle composition and methods for using the same
|
US20070071683A1
(en)
*
|
2005-09-27 |
2007-03-29 |
The Regents Of The University Of California |
Ultrasonic concentration of carrier particles
|
WO2007070682A2
(en)
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
EP2674440B1
(de)
|
2005-12-16 |
2019-07-03 |
IBC Pharmaceuticals, Inc. |
Polyvalente bioaktive anordnungen auf immunglobulinbasis
|
US20070156230A1
(en)
|
2006-01-04 |
2007-07-05 |
Dugan Stephen R |
Stents with radiopaque markers
|
CA2643306C
(en)
*
|
2006-02-21 |
2016-05-03 |
Millikelvin Technologies Llc |
Hyperpolarization methods, systems and compositions
|
US8021689B2
(en)
*
|
2006-02-21 |
2011-09-20 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
Nanoparticles for immunotherapy
|
AU2013205838B2
(en)
*
|
2006-02-21 |
2016-03-17 |
Avrum Belzer |
Hyperpolarization Methods, Systems and Compositions
|
KR100848932B1
(ko)
*
|
2006-02-24 |
2008-07-29 |
(주)에이티젠 |
자성 나노복합체를 이용하여 표적 물질을 분리하는 방법
|
US20070218007A1
(en)
*
|
2006-03-17 |
2007-09-20 |
Allergan, Inc. |
Ophthalmic visualization compositions and methods of using same
|
US20070225472A1
(en)
*
|
2006-03-23 |
2007-09-27 |
Varshney Sunil K |
Polyanhydride polymers and their uses in biomedical devices
|
EP2007435B1
(de)
|
2006-03-31 |
2019-12-18 |
Massachusetts Institute Of Technology |
System zur gezielten verabreichung von heilmitteln
|
JP5630998B2
(ja)
|
2006-05-15 |
2014-11-26 |
マサチューセッツ インスティテュート オブ テクノロジー |
機能的粒子のためのポリマー
|
US20130325105A1
(en)
|
2006-05-26 |
2013-12-05 |
Abbott Cardiovascular Systems Inc. |
Stents With Radiopaque Markers
|
EP2032614A2
(de)
|
2006-06-06 |
2009-03-11 |
Rutgers, The State University Of New Jersey |
Jodhaltige polymere
|
US8535372B1
(en)
|
2006-06-16 |
2013-09-17 |
Abbott Cardiovascular Systems Inc. |
Bioabsorbable stent with prohealing layer
|
US9381477B2
(en)
|
2006-06-23 |
2016-07-05 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
US8128688B2
(en)
|
2006-06-27 |
2012-03-06 |
Abbott Cardiovascular Systems Inc. |
Carbon coating on an implantable device
|
US7823263B2
(en)
|
2006-07-11 |
2010-11-02 |
Abbott Cardiovascular Systems Inc. |
Method of removing stent islands from a stent
|
EP3061791B1
(de)
|
2006-07-20 |
2019-01-16 |
OrbusNeich Medical, Inc. |
Bioresorbierbare polymerzusammensetzung für eine medizinische vorrichtung
|
US8016879B2
(en)
|
2006-08-01 |
2011-09-13 |
Abbott Cardiovascular Systems Inc. |
Drug delivery after biodegradation of the stent scaffolding
|
WO2008026702A1
(en)
*
|
2006-08-30 |
2008-03-06 |
Kyushu University, National University Corporation |
Pharmaceutical composition containing statin-encapsulated nanoparticle
|
ES2360538T3
(es)
*
|
2006-09-08 |
2011-06-06 |
Johns Hopkins University |
Composiciones para aumentar el transporte a través de moco.
|
KR100946275B1
(ko)
*
|
2006-09-26 |
2010-03-08 |
주식회사 삼양사 |
수 난용성 캄토테신 유도체의 미세 나노입자 및 그의제조방법
|
US7959942B2
(en)
|
2006-10-20 |
2011-06-14 |
Orbusneich Medical, Inc. |
Bioabsorbable medical device with coating
|
CN101631513B
(zh)
|
2006-10-20 |
2013-06-05 |
奥巴斯尼茨医学公司 |
可生物吸收的聚合物组合物和医疗设备
|
US20110223232A1
(en)
*
|
2006-10-23 |
2011-09-15 |
Olexander Hnojewyj |
drug-release composition having a therapeutic carrier
|
WO2008084286A2
(en)
|
2006-10-25 |
2008-07-17 |
Arterial Remodeling Technologies, S.A. |
Method for expansion and deployment of polymeric structures including stents
|
US11712510B2
(en)
|
2006-11-27 |
2023-08-01 |
Frank Levy |
Delivery system and method for the effective, reliable and foolproof delivery of controlled amounts of a medical fluid
|
US10149935B2
(en)
*
|
2006-11-27 |
2018-12-11 |
Frank Levy |
Delivery system and method for the effective and reliable delivery of controlled amounts of a medical fluid
|
WO2008091465A2
(en)
*
|
2006-12-21 |
2008-07-31 |
Wayne State University |
Peg and targeting ligands on nanoparticle surface
|
KR100809402B1
(ko)
|
2007-01-29 |
2008-03-05 |
김정환 |
나노 입자 표지, 나노 입자 표지를 이용하는 진단 키트, 및진단 방법
|
GB0701896D0
(en)
*
|
2007-02-01 |
2007-03-14 |
Regentec Ltd |
Composition
|
US9217129B2
(en)
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
US10265407B2
(en)
|
2007-02-15 |
2019-04-23 |
Yale University |
Modular nanodevices for smart adaptable vaccines
|
WO2008115641A2
(en)
|
2007-02-15 |
2008-09-25 |
Yale University |
Modular nanoparticles for adaptable vaccines
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
EP2144600A4
(de)
|
2007-04-04 |
2011-03-16 |
Massachusetts Inst Technology |
Poly (aminsäure)-zielmoleküle
|
US8703204B2
(en)
|
2007-05-03 |
2014-04-22 |
Bend Research, Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
|
WO2008135828A2
(en)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
EP2167069B1
(de)
|
2007-05-23 |
2011-10-26 |
Amcol International Corporation |
Mit cholesterin interagierende phyllosilikate und verfahren zur reduktion von hypercholesterinämie bei einem säuger
|
WO2008149192A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
US9545384B2
(en)
|
2007-06-04 |
2017-01-17 |
Bend Research, Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
|
US7901452B2
(en)
|
2007-06-27 |
2011-03-08 |
Abbott Cardiovascular Systems Inc. |
Method to fabricate a stent having selected morphology to reduce restenosis
|
US7955381B1
(en)
|
2007-06-29 |
2011-06-07 |
Advanced Cardiovascular Systems, Inc. |
Polymer-bioceramic composite implantable medical device with different types of bioceramic particles
|
US9125807B2
(en)
|
2007-07-09 |
2015-09-08 |
Incept Llc |
Adhesive hydrogels for ophthalmic drug delivery
|
WO2009012372A1
(en)
|
2007-07-18 |
2009-01-22 |
Advantageous Systems, Llc |
Methods and apparatuses for detecting analytes in biological fluid of an animal
|
US9097644B2
(en)
*
|
2007-08-17 |
2015-08-04 |
Massachusetts Institute Of Technology |
Magnetic resonance-based viscometers and methods
|
SG150405A1
(en)
*
|
2007-08-29 |
2009-03-30 |
Agency Science Tech & Res |
Method of coating a particle
|
CA2891005A1
(en)
*
|
2007-09-28 |
2008-10-09 |
Bind Therapeutics, Inc. |
Cancer cell targeting using nanoparticles
|
MX2010003642A
(es)
|
2007-10-12 |
2010-08-09 |
Massachusetts Inst Technology |
Nanotecnologia de vacuna.
|
EP2231169B1
(de)
|
2007-12-06 |
2016-05-04 |
Bend Research, Inc. |
Pharmazeutische zusammensetzungen mit nanopartikeln und resuspensionsmaterial
|
US9233078B2
(en)
|
2007-12-06 |
2016-01-12 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
|
US20110027172A1
(en)
*
|
2007-12-10 |
2011-02-03 |
Zhuang Wang |
Drug delivery system for pharmaceuticals and radiation
|
US8728528B2
(en)
|
2007-12-20 |
2014-05-20 |
Evonik Corporation |
Process for preparing microparticles having a low residual solvent volume
|
WO2009152265A1
(en)
*
|
2008-06-10 |
2009-12-17 |
The Board Of Trustees Of The University Of Arkansas |
Indium arsenide nanocrystals and methods of making the same
|
JP2012501965A
(ja)
|
2008-06-16 |
2012-01-26 |
バインド バイオサイエンシズ インコーポレイテッド |
薬剤を装填したポリマーナノ粒子及びその製造方法と使用方法
|
JP2012501966A
(ja)
*
|
2008-06-16 |
2012-01-26 |
バインド バイオサイエンシズ インコーポレイテッド |
ビンカアルカロイド含有治療用ポリマーナノ粒子並びにその製造方法及び使用方法
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
US20100055041A1
(en)
*
|
2008-08-28 |
2010-03-04 |
Dong June Ahn |
Nanotracer for in-situ gastric cancer detection
|
WO2010039865A2
(en)
*
|
2008-10-01 |
2010-04-08 |
Cornell University |
Biodegradable chemical delivery system
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
WO2010068866A2
(en)
|
2008-12-12 |
2010-06-17 |
Bind Biosciences |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
ES2776126T3
(es)
|
2008-12-15 |
2020-07-29 |
Pfizer |
Nanopartículas de circulación prolongada para la liberación sostenida de agentes terapéuticos
|
CA2750242C
(en)
|
2009-02-12 |
2018-05-22 |
Incept, Llc |
Drug delivery through hydrogel plugs
|
US8580230B2
(en)
*
|
2009-02-23 |
2013-11-12 |
Kent State University |
Materials and methods for MRI contrast agents and drug delivery
|
WO2010114770A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
EA201171195A8
(ru)
*
|
2009-03-30 |
2014-08-29 |
Серулин Фарма Инк. |
Конъюгаты, частицы, композиции "полимер-агент" и способы их применения
|
WO2010114768A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-epothilone conjugates, particles, compositions, and related methods of use
|
US9636384B2
(en)
|
2009-04-06 |
2017-05-02 |
Mayo Foundation For Medical Education And Research |
Methods for making polymeric nanoparticle-polypeptide complex
|
EP2435094A2
(de)
|
2009-05-27 |
2012-04-04 |
Selecta Biosciences, Inc. |
Gezielt ausgerichtete synthetische nanoträger mit ph-sensitiver freisetzung von immunmodulatorischen stoffen
|
WO2011031298A1
(en)
*
|
2009-08-26 |
2011-03-17 |
Selecta Biosciences, Inc. |
Compositions that induce t cell help
|
US9205155B2
(en)
|
2009-10-30 |
2015-12-08 |
General Electric Company |
Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents
|
EP2509634B1
(de)
|
2009-12-11 |
2019-03-06 |
Pfizer Inc |
Stabile formulierungen zur lyophilisation therapeutischer partikel
|
ES2780156T3
(es)
|
2009-12-15 |
2020-08-24 |
Pfizer |
Composiciones terapéuticas de nanopartículas poliméricas con alta temperatura de transición vítrea o copolímeros de alto peso molecular
|
EP2512487A4
(de)
*
|
2009-12-15 |
2013-08-07 |
|
Therapeutische polymernanopartikel mit corticosteroiden sowie verfahren zu deren herstellung und verwendung
|
EP3960215A1
(de)
*
|
2009-12-15 |
2022-03-02 |
Incept, LLC |
Implantate und biologisch abbaubare bezugsmarkierungen
|
CN102791294A
(zh)
*
|
2009-12-16 |
2012-11-21 |
布里格姆妇女医院股份有限公司 |
用于多种药物递送的粒子
|
EP2531220B1
(de)
|
2009-12-18 |
2018-05-02 |
President and Fellows of Harvard College |
Aktive gerüste für on-demand-freisetzung von wirkstoffen und zellen
|
EP2523680A4
(de)
*
|
2010-01-11 |
2013-06-19 |
Ct Molecular Med & Immunology |
Verstärkte zytotoxizität von antikörpern gegen cd74 und hla-dr mit interferon-gamma
|
US8808353B2
(en)
|
2010-01-30 |
2014-08-19 |
Abbott Cardiovascular Systems Inc. |
Crush recoverable polymer scaffolds having a low crossing profile
|
US8568471B2
(en)
|
2010-01-30 |
2013-10-29 |
Abbott Cardiovascular Systems Inc. |
Crush recoverable polymer scaffolds
|
US8889193B2
(en)
|
2010-02-25 |
2014-11-18 |
The Johns Hopkins University |
Sustained delivery of therapeutic agents to an eye compartment
|
US20110236496A1
(en)
*
|
2010-03-26 |
2011-09-29 |
Peter Markland |
Emulsions for Microencapsulation Comprising Biodegradable Surface-Active Block Copolymers as Stabilizers
|
US8808357B2
(en)
*
|
2010-04-06 |
2014-08-19 |
Poly-Med, Inc. |
Radiopaque iodinated and iodide-containing crystalline absorbable aliphatic polymeric materials and applications thereof
|
BR112012029912A2
(pt)
|
2010-05-26 |
2016-11-16 |
Selecta Biosciences Inc |
vácinas de combinação de nanotransportadores sintéticos
|
US9364568B2
(en)
*
|
2010-07-15 |
2016-06-14 |
Warsaw Orthopedic, Inc. |
Methods to diagnose degenerative disc disease
|
BR112013003823A2
(pt)
*
|
2010-08-20 |
2016-06-28 |
Cerulean Pharma Inc |
conjugados de peptídeo terapêutico-políemro, partículas, composições, e métodos relacionados
|
RU2013112654A
(ru)
|
2010-08-30 |
2014-10-10 |
Президент Энд Феллоуз Ов Харвард Колледж |
Высвобождение, контролируемое сдвигом, для повреждений, вызванных стенозом, и тромболитических терапий
|
US10307372B2
(en)
|
2010-09-10 |
2019-06-04 |
The Johns Hopkins University |
Rapid diffusion of large polymeric nanoparticles in the mammalian brain
|
US8961501B2
(en)
|
2010-09-17 |
2015-02-24 |
Incept, Llc |
Method for applying flowable hydrogels to a cornea
|
US9782342B2
(en)
|
2010-10-11 |
2017-10-10 |
Wichita State University |
Composite magnetic nanoparticle drug delivery system
|
ES2576927T3
(es)
|
2010-10-22 |
2016-07-12 |
T2 Biosystems, Inc. |
Sistemas de RMN y métodos para la detección rápida de analitos
|
US8409807B2
(en)
|
2010-10-22 |
2013-04-02 |
T2 Biosystems, Inc. |
NMR systems and methods for the rapid detection of analytes
|
US8563298B2
(en)
|
2010-10-22 |
2013-10-22 |
T2 Biosystems, Inc. |
NMR systems and methods for the rapid detection of analytes
|
EP2640190A4
(de)
|
2010-11-05 |
2016-05-11 |
Selecta Biosciences Inc |
Modifizierte nikotinische verbindungen und zugehörige verfahren
|
MX347090B
(es)
|
2010-12-29 |
2017-04-11 |
Medincell |
Composiciones de suministro de farmacos biodegradables.
|
US20120202239A1
(en)
*
|
2011-02-04 |
2012-08-09 |
Ezekiel Kruglick |
Materials, monitoring, and controlling tissue growth using magnetic nanoparticles
|
WO2012109363A2
(en)
|
2011-02-08 |
2012-08-16 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
US9713702B2
(en)
*
|
2011-03-14 |
2017-07-25 |
The Board Of Trustee Of The Leland Stanford Junior University |
Methods of electric field induced delivery of compounds, compositions used in delivery, and systems of delivery
|
EP2704715B1
(de)
|
2011-04-29 |
2020-04-01 |
Selecta Biosciences, Inc. |
Synthetische nanoträger zur erzeugung cd8+-regulierender t-zellen zur verwendung bei der induktion von tolerogenese
|
US9801829B2
(en)
*
|
2011-04-29 |
2017-10-31 |
University Of Florida Research Foundation, Inc. |
Methods and systems of making nanostructures
|
JP2014518862A
(ja)
*
|
2011-05-09 |
2014-08-07 |
インスティトゥト・キミク・デ・サリア |
薬物送達用ポリマーナノ粒子
|
SG10201608671SA
(en)
|
2011-07-18 |
2016-12-29 |
Harvard College |
Engineered Microbe-Targeting Molecules and Uses Thereof
|
US8726483B2
(en)
|
2011-07-29 |
2014-05-20 |
Abbott Cardiovascular Systems Inc. |
Methods for uniform crimping and deployment of a polymer scaffold
|
WO2013019669A2
(en)
|
2011-07-29 |
2013-02-07 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
AU2012345732B2
(en)
|
2011-11-30 |
2016-07-14 |
Emory University |
Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
|
WO2013085893A1
(en)
|
2011-12-05 |
2013-06-13 |
Immunomedics, Inc. |
Therapeutic use of anti-cd22 antibodies for inducing trogocytosis
|
US9757458B2
(en)
|
2011-12-05 |
2017-09-12 |
Immunomedics, Inc. |
Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in hematopoietic cancer cells
|
CA2863632C
(en)
|
2012-01-19 |
2017-07-11 |
The Johns Hopkins University |
Nanoparticle formulations with enhanced mucosal penetration
|
US8927529B2
(en)
|
2012-01-30 |
2015-01-06 |
SpineThera |
Treatment of back pain by injection of microparticles of dexamethasone acetate and a polymer
|
US20130236504A1
(en)
|
2012-03-06 |
2013-09-12 |
Medical University Of South Carolina |
Delivery System for Enhancing Drug Efficacy
|
US10159743B2
(en)
|
2012-03-16 |
2018-12-25 |
The Johns Hopkins University |
Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
|
US8962577B2
(en)
|
2012-03-16 |
2015-02-24 |
The Johns Hopkins University |
Controlled release formulations for the delivery of HIF-1 inhibitors
|
EP2839038B1
(de)
|
2012-04-20 |
2019-01-16 |
T2 Biosystems, Inc. |
Zusammensetzungen und verfahren für den nachweis einer candida-spezies
|
WO2013163176A1
(en)
|
2012-04-23 |
2013-10-31 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
KR102154880B1
(ko)
|
2012-05-03 |
2020-09-10 |
칼라 파마슈티컬스, 인크. |
개선된 점막 수송을 나타내는 제약 나노입자
|
US9056057B2
(en)
|
2012-05-03 |
2015-06-16 |
Kala Pharmaceuticals, Inc. |
Nanocrystals, compositions, and methods that aid particle transport in mucus
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US9533068B2
(en)
|
2012-05-04 |
2017-01-03 |
The Johns Hopkins University |
Drug loaded microfiber sutures for ophthalmic application
|
JP6392209B2
(ja)
|
2012-05-04 |
2018-09-19 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
粘液内層を通過する迅速な透過のための脂質ベース薬物キャリア
|
EA032943B1
(ru)
|
2012-09-17 |
2019-08-30 |
Пфайзер Инк. |
Способ получения терапевтических наночастиц (варианты) и терапевтическая наночастица (варианты)
|
CN103830741B
(zh)
*
|
2012-11-27 |
2019-02-19 |
杨子剑 |
含有陶扎色替类似物结构的化合物以及制备方法和用途
|
CN103848986B
(zh)
*
|
2012-11-28 |
2019-10-11 |
杨子剑 |
含有头孢菌素结构的化合物以及制备方法和用途
|
CN103848901A
(zh)
*
|
2012-11-28 |
2014-06-11 |
杨子剑 |
含有万古霉素结构的新化合物以及制备方法和用途
|
CN103848894A
(zh)
*
|
2012-11-30 |
2014-06-11 |
杨子剑 |
含有达托霉素结构的新化合物以及制备方法和用途
|
US9492566B2
(en)
|
2012-12-13 |
2016-11-15 |
Immunomedics, Inc. |
Antibody-drug conjugates and uses thereof
|
US10137196B2
(en)
|
2012-12-13 |
2018-11-27 |
Immunomedics, Inc. |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
|
US10206918B2
(en)
|
2012-12-13 |
2019-02-19 |
Immunomedics, Inc. |
Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers
|
EP2900277B1
(de)
|
2012-12-13 |
2022-02-16 |
Immunomedics, Inc. |
Dosierungen von immunkonjugaten von antikörpern und sn-38 für verbesserte wirksamkeit und reduzierte toxizität
|
US10413539B2
(en)
|
2012-12-13 |
2019-09-17 |
Immunomedics, Inc. |
Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132)
|
US9931417B2
(en)
|
2012-12-13 |
2018-04-03 |
Immunomedics, Inc. |
Antibody-SN-38 immunoconjugates with a CL2A linker
|
ES2819573T3
(es)
|
2012-12-13 |
2021-04-16 |
Immunomedics Inc |
Método para producir inmunoconjugados de anticuerpo-SN-38 con un enlazador CL2A
|
US10744129B2
(en)
|
2012-12-13 |
2020-08-18 |
Immunomedics, Inc. |
Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inhibiting antibody-drug conjugate (ADC) targeting Trop-2
|
US10568975B2
(en)
|
2013-02-05 |
2020-02-25 |
The Johns Hopkins University |
Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
|
US9468681B2
(en)
|
2013-03-01 |
2016-10-18 |
California Institute Of Technology |
Targeted nanoparticles
|
WO2014144325A1
(en)
|
2013-03-15 |
2014-09-18 |
President And Fellows Of Harvard College |
Methods and compositions for improving detection and/or capture of a target entity
|
KR102233251B1
(ko)
|
2013-04-03 |
2021-03-26 |
엔-폴드 엘엘씨 |
신규 나노입자 조성물
|
CN105339012A
(zh)
|
2013-05-03 |
2016-02-17 |
西莱克塔生物科技公司 |
降低i型和iv型超敏反应的致耐受性合成纳米载体的局部伴随施用
|
JP6649250B2
(ja)
|
2013-05-21 |
2020-02-19 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
操作されたヘム結合性構成物およびその使用
|
EA201592273A1
(ru)
|
2013-06-04 |
2016-09-30 |
Селекта Байосайенсиз, Инк. |
Повторное введение неиммуносупрессивных антигенспецифических иммунотерапевтических средств
|
US11253606B2
(en)
|
2013-07-23 |
2022-02-22 |
Immunomedics, Inc. |
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, Bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer
|
CN105037710A
(zh)
*
|
2013-09-01 |
2015-11-11 |
韩冰 |
新化合物的制备方法及其在医疗中的新用途
|
SI3311845T1
(sl)
|
2013-09-16 |
2020-06-30 |
Astrazeneca Ab |
Terapevtski polimerni nanodelci in postopki njihove izdelave in uporabe
|
US10513546B2
(en)
|
2013-12-18 |
2019-12-24 |
President And Fellows Of Harvard College |
CRP capture/detection of gram positive bacteria
|
WO2015127389A1
(en)
|
2014-02-23 |
2015-08-27 |
The Johns Hopkins University |
Hypotonic enema formulations and methods of use
|
ME03435B
(de)
|
2014-03-14 |
2020-01-20 |
Pfizer |
Therapeutische nanopartikel mit einem behandlungsmittel sowie verfahren zur herstellung und verwendung davon
|
WO2015175545A1
(en)
|
2014-05-12 |
2015-11-19 |
The Johns Hopkins University |
Highly stable biodegradable gene vector platforms for overcoming biological barriers
|
ES2960601T3
(es)
|
2014-06-12 |
2024-03-05 |
Cedars Sinai Medical Center |
Composiciones y métodos para el tratamiento del cáncer
|
EP3160449B1
(de)
|
2014-06-24 |
2023-12-13 |
The Trustees of Princeton University |
Verfahren zum einkapseln von löslichen biologika, therapeutika und kontrastmitteln
|
EA201692512A1
(ru)
|
2014-06-25 |
2017-07-31 |
Селекта Байосайенсиз, Инк. |
Способы и композиции для лечения синтетическими наноносителями и ингибиторами иммунной контрольной точки
|
EP3190417A4
(de)
|
2014-09-02 |
2018-04-18 |
LSI Medience Corporation |
Polymermikropartikel zum tragen von einer physiologisch aktiven substanz und verfahren zur herstellung davon
|
US10046064B2
(en)
|
2014-09-07 |
2018-08-14 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses
|
JP7218089B2
(ja)
|
2014-11-05 |
2023-02-06 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
安定した過飽和状態でラパマイシンをもつ合成ナノキャリアに関する方法および組成物
|
JP6847848B2
(ja)
*
|
2014-12-15 |
2021-03-24 |
ザ ジョーンズ ホプキンズ ユニバーシティThe Johns Hopkins University |
スニチニブ製剤、及び緑内障の治療におけるその使用方法
|
JP6846351B2
(ja)
|
2015-01-27 |
2021-03-24 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
粘膜表面における活性薬剤の増強された輸送のための低張ヒドロゲル製剤
|
US9999527B2
(en)
|
2015-02-11 |
2018-06-19 |
Abbott Cardiovascular Systems Inc. |
Scaffolds having radiopaque markers
|
US9737368B2
(en)
|
2015-02-24 |
2017-08-22 |
Abbott Cardiovascular Systems Inc. |
System and method for attaching a radiopaque marker bead to an endoprosthesis
|
JP6746845B2
(ja)
|
2015-04-22 |
2020-08-26 |
イミューノメディクス、インコーポレイテッドImmunomedics, Inc. |
循環trop−2陽性癌細胞の単離、検出、診断及び/または特徴付け
|
US9700443B2
(en)
|
2015-06-12 |
2017-07-11 |
Abbott Cardiovascular Systems Inc. |
Methods for attaching a radiopaque marker to a scaffold
|
US10195175B2
(en)
|
2015-06-25 |
2019-02-05 |
Immunomedics, Inc. |
Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors
|
CN111643479B
(zh)
|
2015-07-01 |
2023-10-27 |
加州理工学院 |
基于阳离子粘酸聚合物的递送系统
|
WO2017024114A1
(en)
|
2015-08-06 |
2017-02-09 |
President And Fellows Of Harvard College |
Improved microbe-binding molecules and uses thereof
|
WO2017035408A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Compounds for treatment of immune and inflammatory disorders
|
AR106018A1
(es)
|
2015-08-26 |
2017-12-06 |
Achillion Pharmaceuticals Inc |
Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
|
KR20180075650A
(ko)
*
|
2015-10-30 |
2018-07-04 |
더 존스 홉킨스 유니버시티 |
고분자량 및 고밀도 코팅을 갖는 점액 침투성 입자
|
CN108367079B
(zh)
|
2015-11-12 |
2022-11-22 |
灰色视觉公司 |
用于治疗的聚集性微粒
|
ES2964696T3
(es)
|
2015-11-16 |
2024-04-09 |
Medincell S A |
Un método para morselizar y/o dirigir principios farmacéuticamente activos al tejido sinovial
|
US11103461B2
(en)
|
2015-12-22 |
2021-08-31 |
The Trustees Of Princeton University |
Process for encapsulating soluble biologics, therapeutics, and imaging agents
|
EP3405479A4
(de)
|
2016-01-21 |
2019-08-21 |
T2 Biosystems, Inc. |
Nmr-verfahren und -systeme zur schnellen detektion von bakterien
|
CN108601841A
(zh)
|
2016-02-10 |
2018-09-28 |
免疫医疗公司 |
Abcg2抑制剂与sacituzumab govitecan(immu-132)的组合克服表达trop-2的癌中对sn-38的抗性
|
WO2017147169A1
(en)
|
2016-02-22 |
2017-08-31 |
Ohio State Innovation Foundation |
Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin a analogues or metabolites, and estradiol metabolites
|
KR20220123332A
(ko)
|
2016-03-11 |
2022-09-06 |
셀렉타 바이오사이언시즈, 인크. |
Peg화 우리카제의 제제 및 용량
|
CN105859933B
(zh)
*
|
2016-03-31 |
2018-09-21 |
北京化工大学 |
一种具有核壳结构的反应型聚合物微球及其制备方法和应用
|
CA3016917A1
(en)
|
2016-04-27 |
2017-11-02 |
Immunomedics, Inc. |
Efficacy of anti-trop-2-sn-38 antibody drug conjugates for therapy of tumors relapsed/refractory to checkpoint inhibitors
|
EP3454862A4
(de)
|
2016-05-10 |
2020-02-12 |
C4 Therapeutics, Inc. |
Spirocyclische degronimere für zielproteinabbau
|
WO2017197055A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Heterocyclic degronimers for target protein degradation
|
CN109641874A
(zh)
|
2016-05-10 |
2019-04-16 |
C4医药公司 |
用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
|
RU2018145364A
(ru)
|
2016-06-27 |
2020-07-28 |
Ачиллион Фармасьютикалс, Инк. |
Хиназолиновые и индольные соединения для лечения медицинских нарушений
|
KR20190025943A
(ko)
|
2016-07-01 |
2019-03-12 |
쥐원 쎄라퓨틱스, 인크. |
피리미딘-기재 항증식제
|
EP3518956A1
(de)
|
2016-09-27 |
2019-08-07 |
Selecta Biosciences, Inc. |
Rekombinante immunotoxine zur verwendung bei der behandlung von krebs
|
CN110177553A
(zh)
|
2016-11-17 |
2019-08-27 |
北卡罗来纳大学教堂山分校 |
烷基吡咯并嘧啶类似物及其制备和使用方法
|
BR112019013862A2
(pt)
|
2017-01-07 |
2020-04-14 |
Selecta Biosciences Inc |
dosagem padrão de imunossupressores acoplados a nanocarreadores sintéticos
|
EP3592389A1
(de)
|
2017-03-11 |
2020-01-15 |
Selecta Biosciences, Inc. |
Verfahren und zusammensetzungen in zusammenhang mit einer kombinierten behandlung mit entzündungshemmenden mitteln und synthetischen nanoträgern mit einem immunsuppressivum
|
CA3056923A1
(en)
|
2017-03-23 |
2018-09-27 |
Graybug Vision, Inc. |
Drugs and compositions for the treatment of ocular disorders
|
EP3600283A4
(de)
|
2017-03-27 |
2020-12-16 |
Immunomedics, Inc. |
Behandlung von trop-2-exprimierendem triple-negativem brustkrebs mit sacituzumab govitecan und einem rad51-hemmer
|
CA3044082A1
(en)
|
2017-04-03 |
2018-10-11 |
Immunomedics, Inc. |
Subcutaneous administration of antibody-drug conjugates for cancer therapy
|
MX2019013363A
(es)
|
2017-05-10 |
2020-01-13 |
Graybug Vision Inc |
Microparticulas de liberacion extendida y suspensiones de las mismas para terapia medica.
|
WO2019055539A1
(en)
|
2017-09-12 |
2019-03-21 |
Prudhomme Robert K |
CELLULOSIC POLYMER NANOPARTICLES AND METHODS OF FORMING THE SAME
|
BR112020007157A2
(pt)
|
2017-10-13 |
2020-09-24 |
Selecta Biosciences, Inc. |
métodos e composições para a atenuação de respostas de igm antivetor de transferência viral
|
EP3470056B1
(de)
*
|
2017-10-16 |
2022-04-27 |
Medtronic Vascular Inc. |
Therapeutische nanopartikel zur behandlung von gefässerkrankungen
|
EP3773576A4
(de)
|
2018-03-26 |
2021-12-29 |
C4 Therapeutics, Inc. |
Cereblon-bindemittel zum abbau von ikaros
|
KR20210032438A
(ko)
|
2018-07-16 |
2021-03-24 |
셀렉타 바이오사이언시즈, 인크. |
Otc 구축물 및 벡터의 방법 및 조성물
|
EP3823676A1
(de)
|
2018-07-16 |
2021-05-26 |
Selecta Biosciences, Inc. |
Verfahren und zusammensetzungen von mma-konstrukten und vektoren
|
US11731099B2
(en)
|
2018-07-20 |
2023-08-22 |
The Trustees Of Princeton University |
Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation
|
EP3841086A4
(de)
|
2018-08-20 |
2022-07-27 |
Achillion Pharmaceuticals, Inc. |
Pharmazeutische zusammensetzungen zur behandlung von medizinischen störungen im zusammenhang mit komplementfaktor d
|
CN113365617A
(zh)
|
2018-10-16 |
2021-09-07 |
乔治亚州立大学研究基金会股份有限公司 |
用于医学疾病治疗的一氧化碳前药
|
US10987315B1
(en)
|
2018-12-04 |
2021-04-27 |
University Of South Florida |
Antithrombotic nanoparticles and methods for treating necrotizing enterocolitis
|
US20220106584A1
(en)
|
2019-01-14 |
2022-04-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and kits for generating and selecting a variant of a binding protein with increased binding affinity and/or specificity
|
MX2021013163A
(es)
|
2019-04-28 |
2022-02-21 |
Selecta Biosciences Inc |
Métodos para el tratamiento de sujetos con inmunidad preexistente a vectores de transferencia viral.
|
US11471412B1
(en)
|
2019-05-10 |
2022-10-18 |
University Of South Florida |
Nanoparticles and nanogel drug compositions for treatment of age-related macular degeneration
|
WO2020243261A1
(en)
|
2019-05-28 |
2020-12-03 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuated anti-viral transfer vector immune response
|
AU2020287627A1
(en)
|
2019-06-04 |
2021-11-18 |
Selecta Biosciences, Inc. |
Formulations and doses of PEGylated uricase
|
US20210154324A1
(en)
|
2019-10-21 |
2021-05-27 |
Selecta Biosciences, Inc. |
Methods and compositions for treating liver diseases and disorders
|
US20210187081A1
(en)
|
2019-11-08 |
2021-06-24 |
Selecta Biosciences, Inc. |
Formulations and doses of pegylated uricase
|
KR20220146559A
(ko)
|
2020-02-26 |
2022-11-01 |
셀렉타 바이오사이언시즈, 인크. |
면역억제제를 포함하는 합성 나노담체를 사용하는 방법 및 조성물
|
WO2021183781A1
(en)
|
2020-03-11 |
2021-09-16 |
Selecta Biosciences, Inc. |
Methods and compositions related to synthetic nanocarriers
|
AU2020442489A1
(en)
|
2020-04-14 |
2022-11-10 |
Selecta Biosciences, Inc. |
Methods and compositions for inducing autophagy
|
CA3194232A1
(en)
|
2020-09-29 |
2022-04-07 |
Daniel Beard |
Stroke treatment
|
JP2024502115A
(ja)
|
2021-01-05 |
2024-01-17 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
ウイルスベクター投薬プロトコル
|
IL307481A
(en)
|
2021-04-09 |
2023-12-01 |
Selecta Biosciences Inc |
Synthetic nanocarriers containing an immune system suppressor combined with IL-2 receptor agonists with high affinity for increasing immune tolerance
|
US20230140196A1
(en)
|
2021-10-12 |
2023-05-04 |
Selecta Biosciences, Inc. |
Viral vector dosing protocols
|
WO2023064367A1
(en)
|
2021-10-12 |
2023-04-20 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating anti-viral transfer vector igm responses
|
WO2023086615A1
(en)
|
2021-11-14 |
2023-05-19 |
Selecta Biosciences, Inc. |
Multiple dosing with viral vectors
|
US20230263906A1
(en)
|
2022-01-10 |
2023-08-24 |
Selecta Biosciences, Inc. |
High affinity il-2 receptor agonists and synthetic nanocarrier dose sparing
|
WO2023172628A1
(en)
|
2022-03-09 |
2023-09-14 |
Selecta Biosciences, Inc. |
Immunosuppressant in combination with high affinity il-2 receptor agonists and related dosing
|
WO2023172624A1
(en)
|
2022-03-09 |
2023-09-14 |
Selecta Biosciences, Inc. |
Immunosuppressants in combination with anti-igm agents and related dosing
|
US20230372535A1
(en)
|
2022-03-25 |
2023-11-23 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers comprising an immunosuppressant in combination with high affinity il-2 receptor agonists and anti-igm agents
|
WO2023196566A1
(en)
|
2022-04-08 |
2023-10-12 |
Selecta Biosciences, Inc. |
High affinity il-2 receptor agonists and immunosuppressants to enhance immune tolerance
|